Cargando…

Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer

Screening for specific biomarkers of early-stage detection of ovarian cancer is a major health priority due to the asymptomatic nature and poor survival characteristic of the disease. We utilised two-dimensional gel electrophoresis (2DE) to identify differentially expressed proteins in the serum of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, N, Barker, G, Oliva, K T, Hoffmann, P, Riley, C, Reeve, S, Smith, A I, Kemp, B E, Quinn, M A, Rice, G E
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364749/ https://www.ncbi.nlm.nih.gov/pubmed/15199385 http://dx.doi.org/10.1038/sj.bjc.6601882

Ejemplares similares

Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours
por: Sotiropoulou, P A, et al.
Publicado: (2003)

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival
por: Wang, Y, et al.
Publicado: (2004)

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors
por: Rehman, I, et al.
Publicado: (2004)

Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis
por: Gasbarri, A, et al.
Publicado: (2004)

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma
por: Zhang, G Y, et al.
Publicado: (2005)

Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing
por: Vassilakos, P, et al.
Publicado: (2002)

Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation
por: Dent, J, et al.
Publicado: (2003)

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker
por: Hoffman, B R, et al.
Publicado: (2002)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer
por: Sauter, E R, et al.
Publicado: (2002)

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer
por: Kupryjańczyk, J, et al.
Publicado: (2004)

Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library
por: Luo, L-Y, et al.
Publicado: (2002)

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma
por: Weichert, W, et al.
Publicado: (2004)

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen
por: Kupryjańczyk, J, et al.
Publicado: (2003)

Prognostic significance of the sequential detection of circulating melanoma cells by RT–PCR in high-risk melanoma patients receiving adjuvant interferon
por: Gogas, H, et al.
Publicado: (2002)

Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR
por: Gal, S, et al.
Publicado: (2004)

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
por: Santin, A D, et al.
Publicado: (2004)

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma
por: Lassus, H, et al.
Publicado: (2004)

Detection of human papillomavirus-16 in ovarian malignancy
por: Wu, Q-J, et al.
Publicado: (2003)

Comparison of the RNA-amplification based methods RT–PCR and NASBA for the detection of circulating tumour cells
por: Burchill, S A, et al.
Publicado: (2002)

The human ovarian surface epithelium is an androgen responsive tissue
por: Edmondson, R J, et al.
Publicado: (2002)

Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line
por: Banerjee, R, et al.
Publicado: (2004)

Predicting biomarkers for ovarian cancer using gene-expression microarrays
por: Adib, T R, et al.
Publicado: (2004)

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
por: Yokoyama, Y, et al.
Publicado: (2003)

Characterisation of human kallikrein 6/protease M expression in ovarian cancer
por: Ni, X, et al.
Publicado: (2004)

Wnt-signalling pathway in ovarian epithelial tumours: increased expression of β-catenin and GSK3β
por: Rask, K, et al.
Publicado: (2003)

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients
por: Ady, N, et al.
Publicado: (2004)

Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells
por: Zhang, X, et al.
Publicado: (2004)

Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer
por: Akahira, J-i, et al.
Publicado: (2004)

Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA
por: Maire, F, et al.
Publicado: (2002)

Transcriptional impairment of β-catenin/E-cadherin complex is not associated with β-catenin mutations in colorectal carcinomas
por: Garinis, G A, et al.
Publicado: (2003)

Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells
por: Junnikkala, S, et al.
Publicado: (2002)

Kallikrein gene downregulation in breast cancer
por: Yousef, G M, et al.
Publicado: (2004)

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
por: Pelosi, G, et al.
Publicado: (2003)

Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?
por: Koukourakis, M I, et al.
Publicado: (2003)

A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens
por: Scott, I S, et al.
Publicado: (2004)

Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma
por: Ahmed, N, et al.
Publicado: (2005)

Particulate debris from a titanium metal prosthesis induces genomic instability in primary human fibroblast cells
por: Coen, N, et al.
Publicado: (2003)

Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system
por: Bøe, A S, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_bhl08rjbgr8f9t8v4bdtnkll1v